Views on artificial intelligence (AI) assisted clinical trials

被引:0
|
作者
Balsundaram, Arthi [1 ]
Stalin, C. [2 ]
Ghanta, Mohan Krishna [3 ]
机构
[1] Biohymns Innovat Pte Ltd, Singapore, Singapore
[2] Indian Pharmacopoeia Commiss, Pharmacovigilance Programme India PVPI, Ghaziabad 201002, India
[3] MVJ Med Coll & Res Hosp, Dept Pharmacol, Bangalore 562114, Karnataka, India
关键词
Artificial intelligence; questionnaire study; clinical trials; WATSON;
D O I
10.6026/97320630017616
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is of interest to document the views of medical professionals on the application of artificial intelligence (using known data for the prediction of unknown events) in clinical trials using a web survery with a structured questionnaire from 377 subjects. The questionnaire contained 17 statements which were categorised into awareness (1,2 statements), perception (3-10 statements) and opinion (11-17 statements). The data obtained was compared between the subjects using two tailed Fisher's exact test with p-value <0.05 for data significance analysis. Data shows that majority of professionals have possitive views on the application of artificial intelligence in clinical trials. This will accelarrate the drug evaluation process. However, the use of emerging tools such as AI will not replace human subjects in this context.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 50 条
  • [1] Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI†
    McGenity, Clare
    Treanor, Darren
    JOURNAL OF PATHOLOGY, 2021, 253 (01): : 14 - 16
  • [2] Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials
    Calaprice-Whitty, Denise
    Galil, Karim
    Salloum, Wael
    Zariv, Ashkon
    Jimenez, Bernal
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (01) : 69 - 74
  • [3] Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials
    Denise Calaprice-Whitty
    Karim Galil
    Wael Salloum
    Ashkon Zariv
    Bernal Jimenez
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 69 - 74
  • [4] AI for Learning: Views on Impacts to Teachership in the era of Artificial Intelligence
    Saukkonen, Juha
    Huhtala, Mari
    Rantonen, Mika
    Vaara, Elina
    PROCEEDINGS OF THE 3RD EUROPEAN CONFERENCE ON THE IMPACT OF ARTIFICIAL INTELLIGENCE AND ROBOTICS (ECIAIR 2021), 2021, : 157 - 165
  • [5] Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines
    Ibrahim, Hussein
    Liu, Xiaoxuan
    Rivera, Samantha Cruz
    Moher, David
    Chan, An-Wen
    Sydes, Matthew R.
    Calvert, Melanie J.
    Denniston, Alastair K.
    TRIALS, 2021, 22 (01)
  • [6] Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines
    Hussein Ibrahim
    Xiaoxuan Liu
    Samantha Cruz Rivera
    David Moher
    An-Wen Chan
    Matthew R. Sydes
    Melanie J. Calvert
    Alastair K. Denniston
    Trials, 22
  • [7] Randomized Clinical Trials of Artificial Intelligence
    Angus, Derek C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11): : 1043 - 1045
  • [8] Artificial Intelligence (AI) Enabled Pre-Screening for Diabetic Retinopathy (DR) Clinical Trials
    Barrett, Nancy
    Slater, Robert
    Channa, Roomasa
    Domalpally, Amitha
    Blodi, Barbara A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [9] Adherence to the SPIRIT-AI Standardized Reporting Guidelines in Artificial Intelligence Clinical Trials in Gastroenterology
    Holzwanger, Erik A.
    Bilal, Mohammad
    Brown, Jeremy Glissen
    Barua, Ishita
    Sawhney, Mandeep S.
    Pleskow, Douglas
    Berzin, Tyler M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S268 - S269
  • [10] The use of artificial intelligence in interpretation of clinical trials
    Stankovski, V
    2ND BALKAN CONGRESS OF ONCOLOGY, 1999, : 51 - 56